Our clinical trials Clinical trials CANOVA (Multiple Myeloma - Recruitment: CLOSED) Project Title A Study of Venetoclax and Dexamethasone Compared With Pomalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma (CANOVA). Official Title A Phase III, Multicenter, Randomized, Open Label Study of Venetoclax and Dexamethasone Compared With Pomalidomide and Dexamethasone in Subjects With t(11;14)-Positive Relapsed or Refractory Multiple Myeloma. Project Summary A study designed to evaluate the safety and efficacy of venetoclax plus dexamethasone (VenDex) compared with pomalidomide plus dexamethasone (PomDex) in participants with t(11;14)-positive Relapsed or Refractory Multiple Myeloma. Blood Disorder t(11;14)-positive Relapsed Multiple Myeloma Refractory Multiple Myeloma Patient Recruitment Details Patient recruitment status: closed Number of Patients (Globally) 244 participants.